BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15763139)

  • 1. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
    Mash DC; Ouyang Q; Qin Y; Pablo J
    J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
    Reith ME; Wang LC; Dutta AK
    J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter.
    Schroeter S; Apparsundaram S; Wiley RG; Miner LH; Sesack SR; Blakely RD
    J Comp Neurol; 2000 May; 420(2):211-32. PubMed ID: 10753308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
    Zhu MY; Shamburger S; Li J; Ordway GA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
    Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
    J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
    Mortensen OV; Amara SG
    J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
    Nandi A; Dersch CM; Kulshrestha M; Ananthan S; Rothman RB
    Synapse; 2004 Sep; 53(3):176-83. PubMed ID: 15236350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional importance of the C-terminus of the human norepinephrine transporter.
    Distelmaier F; Wiedemann P; Brüss M; Bönisch H
    J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
    Sucic S; Bryan-Lluka LJ
    J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds.
    Carroll FI; Tyagi S; Blough BE; Kuhar MJ; Navarro HA
    J Med Chem; 2005 Jun; 48(11):3852-7. PubMed ID: 15916437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
    Tejani-Butt SM
    J Pharmacol Exp Ther; 1992 Jan; 260(1):427-36. PubMed ID: 1731049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
    Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
    J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
    Sucic S; Bryan-Lluka LJ
    Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
    Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
    Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.
    Paczkowski FA; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):312-7. PubMed ID: 11919656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain.
    Hipólide DC; Moreira KM; Barlow KB; Wilson AA; Nobrega JN; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):297-303. PubMed ID: 15694238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of the splicing variants of human norepinephrine transporter.
    Kitayama S; Morita K; Dohi T
    Neurosci Lett; 2001 Oct; 312(2):108-12. PubMed ID: 11595346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine up-regulates norepinephrine transporter binding in the rat placenta.
    Shearman LP; Meyer JS
    Eur J Pharmacol; 1999 Dec; 386(1):1-6. PubMed ID: 10611457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts.
    Jayanthi LD; Vargas G; DeFelice LJ
    Br J Pharmacol; 2002 Apr; 135(8):1927-34. PubMed ID: 11959795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal cocaine exposure reduces myocardial norepinephrine transporter function in the neonatal rat.
    Zhao Y; Sun L
    Neurotoxicol Teratol; 2004; 26(3):443-50. PubMed ID: 15113605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.